TMDX Q3 2020 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M-1.6% YoY

Gross Profit

$5M71.0% margin

Operating Income

-$5M-65.0% margin

Net Income

-$5M-71.8% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+109.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$700,000

Balance Sheet

Total Assets

$159M

Total Liabilities

$50M

Stockholders' Equity

$110M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$7M	-1.6%
Gross Profit	$5M	$4M	+19.5%
Operating Income	-$5M	-$7M	+36.3%
Net Income	-$5M	-$8M	+38.6%

Revenue Segments

Ocs Heart Product

$5M77%

Ocs Liver Product

$1M14%

Ocs Lung Product

$659,0009%

Geographic Segments

UNITED STATES

$6M92%

Non Us And Uk

$491,0008%